3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
1
Interventions
Cyclophosphamide
10
fludarabine
8
Dexamethasone
8
Lenalidomide
6
Bortezomib
5
Granulocyte Colony-Stimulating Factor
4
68Ga-pentixafor
4
Melphalan
3
Filgrastim
3
Positron Emission Tomography Computed Tomography
2
Fluorodeoxyglucose F18
2
Blood Specimen Collection
2
tocilizumab
1
selinexor
1
ruxolitinib
1
pomalidomide
1
pembrolizumab
1
methyl prednisolonate
1
ixazomib
1
ioversol
1
inebilizumab
1
iberdomide
1
fludarabine phosphate
1
eltrombopag
1
elotuzumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
blinatumomab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Diphenhydramine
×
Plasma cell
×
Clear all
NCT05013437
2024-04-02
AHCT
Case Comprehensive Cancer Center
Phase EARLY_PHASE1
Withdrawn